<DOC>
	<DOCNO>NCT00026403</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining radiation therapy chemotherapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy plus radiation therapy treat patient locally advanced pancreatic cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Advanced Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy gemcitabine , cisplatin , radiotherapy , term 1-year survival , patient locally advanced pancreatic cancer . - Determine toxicity regimen patient . - Determine quality life patient treat regimen . OUTLINE : This multicenter study . Patients undergo radiotherapy daily five day week 5.5 week . Patients receive gemcitabine IV 30 minute follow cisplatin IV 1 hour twice week first 3 week radiotherapy . Beginning 4 week completion radiotherapy , patient receive gemcitabine IV 30 minute day 1 , 8 , 15 . Treatment repeat every 28 day total 3 course absence disease progression unacceptable toxicity . Quality life assess baseline , completion radiotherapy , completion chemotherapy , 3 month completion therapy . Patients follow every 3 month 2 year every 6 month 1 year . PROJECTED ACCRUAL : A total 20-47 patient accrue study within 12-28 month .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unresectable adenocarcinoma pancreas No cystadenocarcinoma pancreas pancreatic tumor neuroendocrine origin Prior subtotal resection gross residual disease No microscopic residual disease No metastatic disease outside plan study radiotherapy field PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 2 time upper limit normal ( ULN ) AST great 3 time ULN Renal : Creatinine great 1.5 time ULN Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able maintain adequate oral nutrition No significant infection No medical condition would preclude study No malignancy within past 5 year except nonmelanoma skin cancer No significant nausea vomit PRIOR CONCURRENT THERAPY : Biologic therapy : No prior concurrent biologic therapy Chemotherapy : No prior chemotherapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy would overlap plan study radiotherapy field Surgery : See Disease Characteristics At least 21 day since prior laparotomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>